Publicacións nas que colabora con Luis Miguel Antón Aparicio (6)

2013

  1. Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 425-433

  2. Erratum: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor (Clinical and Translational Oncology DOI: 10.1007/s12094-012-0985-x)

    Clinical and Translational Oncology

2011

  1. Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study

    Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101

  2. Molecular basis of hypertension side effects induced by sunitinib

    Anti-Cancer Drugs, Vol. 22, Núm. 1, pp. 1-8

2010

  1. Renal cell carcinoma: Complete pathological response in a patient with gastric metastasis of renal cell carcinoma

    Anti-Cancer Drugs, Vol. 21, Núm. SUPPL.1

2007

  1. Choroid plexus carcinoma: A rare condition and its therapeutic management

    Clinical and Translational Oncology, Vol. 9, Núm. 6, pp. 401-403